The Clinical Dementia Rating (CDR) is a widely used tool to assess the severity of dementia, including Alzheimer's disease. It evaluates cognitive and functional impairments across six domains: memory, orientation, judgment and problem-solving, community affairs, home and hobbies, and personal care. The CDR scale categorizes individuals into five stages: 0 (no impairment), 0.5 (questionable impairment), 1 (mild), 2 (moderate), and 3 (severe dementia). This structured approach helps clinicians and researchers standardize the assessment of dementia progression and tailor appropriate care plans. By systematically evaluating both cognitive decline and functional abilities, the CDR provides valuable insights into disease severity and helps track changes over time, crucial for understanding the impact of Alzheimer's and other forms of dementia on individuals and guiding clinical interventions.
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Make a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Health care professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Somali Red Crescent Society, Somalia
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States